“clinical-trial” Archives

in
Entry Author Date Location
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Spurned in Duchenne, BioMarin Will Seek Approval For Batten Drug 03/03/16 San Francisco
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
In Murky Regulatory Filings, Idaciti Seeks to Bring Transparency 02/17/16 Boulder/Denver
GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer 02/03/16 Texas
Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game 01/22/16 Boston
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer 01/07/16 San Francisco
Stemina, Eyeing Boston VC, Launches Large Autism Diagnostic Study 09/24/15 Wisconsin
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
Green Park & Golf Brings Swedish Medtech “Cooling Cap” to Dallas 07/07/15 Texas
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
Pushing Past Preclinical, Arsenal and 480 Biomedical Land $26.5M 06/03/15 Boston
Spirox Inhales $18.5M to Advance Nasal Surgery Device 04/21/15 San Francisco
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Two Healthcare Startups Land Venture Funding For Growth 02/10/15 Boston
Madison Vaccines Closes $8M Series A Round for Prostate Treatment 01/13/14 Wisconsin
MVCA Celebrates Year’s Top Deals, Names New Board Chair 11/08/13 Detroit Ann Arbor
FDA Concerns Cause OvaScience To Halt U.S. Trial Of Souped-Up IVF Procedure 09/11/13 Boston
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Hepatitis C Treatments from Gilead, Abbott Wow Liver Meeting 11/13/12 Boston
East Coast Life Sciences Roundup: EpiCept, Boston Scientific, & More 11/09/12 Boston
Aveo Cuts Staff, Announces 3rd Quarter Loss 10/31/12 Boston
Startups Progress with Novel Drugs for Parkinson’s Disease 10/29/12 New York
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Page 1 of 2 next page »